Theranos
The business, the turning points, and the decisions behind them.
01 / WHAT IT BUILT
What the company did
Theranos was a Palo Alto health-technology company founded in 2003 by 19-year-old Stanford dropout Elizabeth Holmes. It claimed its Edison device could run hundreds of accurate blood tests from a few drops of blood — a story that drew over $700M from investors, a $9B peak valuation in 2013-2014, and retail partnerships with Walgreens and Safeway. In October 2015 a Wall Street Journal investigation by John Carreyrou, built on whistleblower accounts, revealed the devices could perform only a fraction of the claimed tests and that most tests were secretly run on conventional machines. Regulatory sanctions, lawsuits and criminal charges followed; the company was dissolved in September 2018.
02 / Theranos FAILURE REASONS
Failure reasons
Theranos's core fraud was technological: the Edison devices never worked as claimed, yet the company sold over 1.5 million blood tests to the public and raised hundreds of millions on false efficacy claims. A culture of secrecy, legal intimidation of whistleblowers (including chief scientist Ian Gibbons) and faked demonstrations for partners like Novartis kept the deception alive. The exposure triggered a cascade: CMS revoked its lab license, Walgreens ended the partnership, the SEC brought fraud charges, and investors' equity was wiped out. Holmes was convicted of wire fraud in January 2022 and sentenced to 11 years and 3 months; former president Sunny Balwani was convicted in July 2022 and sentenced to 12 years and 11 months.
03 / EVENT HISTORY
Events in the structured record
- Founded
19-year-old Stanford dropout Elizabeth Holmes founds Theranos (therapy + diagnosis), promising revolutionary blood testing.
- WSJ exposé
John Carreyrou's Wall Street Journal investigation (October 2015) reveals Theranos's devices performed only ~15 of 240+ tests; the rest were run on conventional machines. CMS sanctions follow.
- Regulatory collapse
CMS revokes Theranos's lab license; Walgreens ends its partnership; the company voids two years of Edison test results and lays off hundreds.
- Fraud charges and dissolution
The SEC charges Theranos, Holmes and Balwani with 'massive fraud' (Holmes fined $500,000 and barred for 10 years). CEO David Taylor's September 2018 letter announces the company will dissolve with ~$5M cash against ~$60M debt.
- Criminal convictions
Holmes is convicted of wire fraud in January 2022 and sentenced to 11 years and 3 months; Balwani is convicted on all 12 counts in July 2022 and sentenced to 12 years and 11 months.
04 / CONTEMPORARY REBUILD ASSESSMENT
Difficulty of rebuilding this project today
Material for this section is being gathered and checked. It will appear here once ready.
Overall assessment: Not completed
05 / CAUSAL CHAIN
How the factors connect
- 01
In September 2018 CEO David Taylor told shareholders Theranos would dissolve after failing to find a buyer, with about $5M in cash left against roughly $60M in debt; lender Fortress Investment Group kept the remaining intellectual property.
- 02
The few remaining employees had their last day on August 31, 2018.
- 03
In March 2018 the SEC charged Theranos, Holmes and Balwani with 'massive fraud'; Holmes paid a $500,000 fine, gave up 19 million shares and was barred from serving as an officer of a public company for 10 years.
- 04
In January 2022 Holmes was convicted of four counts of wire fraud and sentenced to 11 years and 3 months in prison; in July 2022 Balwani was convicted on all 12 counts and sentenced to 12 years and 11 months.